Evidence map›Paper›PMID 28474091›Full record

ArticleVirchows Archiv : an international journal of pathology2017

Cardiac intimal sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing.

Yukinobu Ito, Daichi Maeda, Makoto Yoshida, Akihiko Yoshida, Yukitsugu Kudo-Asabe, Hiroshi Nanjyo, Chikako Izumi, Fumio Yamamoto, Masahiro Inoue, Hiroyuki Shibata and 7 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Rare MDM2 amplification in a fat-predominant angiomyolipoma.Virchows Archiv : an international journal of pathology · 2020
    Article
  10. Genetic aberrations and molecular biology of cardiac sarcoma.Therapeutic advances in medical oncology · 2020
    Review
  11. Article
  12. Activating mutation ofOncotarget · 2017
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Yukinobu ItoDepartment of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Daichi MaedaDepartment of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. maeda-tky@umin.ac.jp.ORCID 0000-0002-9783-1534
Makoto YoshidaDepartment of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Akihiko YoshidaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yukitsugu Kudo-AsabeDepartment of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Hiroshi NanjyoDepartment of Pathology, Akita University Hospital, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Chikako IzumiDepartment of Cardiology, Yokote Municipal Hospital, 5-31 Negishicho, Yokote, Akita, 013-8602, Japan.
Fumio YamamotoDepartment of Cardiovascular Surgery, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Masahiro InoueDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Hiroyuki ShibataDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Hiroto KatohDepartment of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Shumpei IshikawaDepartment of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Hiromi NakamuraDivision of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yasushi TotokiDivision of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Tatsuhiro ShibataDivision of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Shinichi YachidaDivision of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Akiteru GotoDepartment of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Akita University · JPTokyo Medical and Dental University · JPAkita University Hospital · JPNational Cancer Center Hospital East · JPYokosuka Kyosai Hospital · JP

Funding

JSPS KAKENHI 16H01580JSPS KAKENHI 25460431JSPS KAKENHI 26870129National Cancer Center Research and Development Fund 28-A-3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AutopsyFemaleGene AmplificationHeart NeoplasmsHumansMiddle AgedMutationProto-Oncogene Proteins c-mdm2Receptor, Platelet-Derived Growth Factor betaSarcomaMDM2 protein, humanPDGFRB protein, humanProto-Oncogene Proteins c-mdm2Receptor, Platelet-Derived Growth Factor betaCardiac SarcomaCopy Number AlterationIntimal SarcomaMDM2 AmplificationMDM2 Overexpression

Identifiers

PMID28474091
OpenAlexW2611318979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.